These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9200063)

  • 21. The impact of screening on the incidence of cervical cancer in England and Wales.
    Parkin DM; Nguyen-Dinh X; Day NE
    Br J Obstet Gynaecol; 1985 Feb; 92(2):150-7. PubMed ID: 3970894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment.
    Sparén P; Gustafsson L; Friberg LG; Pontén J; Bergström R; Adami HO
    J Clin Oncol; 1995 Mar; 13(3):715-25. PubMed ID: 7884431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the effect of occult invasive cancer on progress towards successful cervical screening.
    Herbert A; Bryant TN; Campbell MJ; Smith J
    J Med Screen; 1998; 5(2):92-8. PubMed ID: 9718528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cervical cancer epidemic that screening has prevented in the UK.
    Peto J; Gilham C; Fletcher O; Matthews FE
    Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cervical cancer: recent trends of incidence and mortality in Lithuania].
    Aleknaviciene B; Smailyte G; Elaawar B; Kurtinaitis J
    Medicina (Kaunas); 2002; 38(2):223-30. PubMed ID: 12474744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
    Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
    Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.
    Day N; McCann J; Camilleri-Ferrante C; Britton P; Hurst G; Cush S; Duffy S
    J Med Screen; 1995; 2(4):180-5. PubMed ID: 8719145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
    Raffle AE; Alden B; Quinn M; Babb PJ; Brett MT
    BMJ; 2003 Apr; 326(7395):901. PubMed ID: 12714468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer in women aged less than 25: East Kent experience.
    Nair MS; Bhandari HM; Nordin AJ
    J Obstet Gynaecol; 2007 Oct; 27(7):706-8. PubMed ID: 17999298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
    Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
    Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK
    Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.
    Foley G; Alston R; Geraci M; Brabin L; Kitchener H; Birch J
    Br J Cancer; 2011 Jun; 105(1):177-84. PubMed ID: 21654675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.